WallStSmart
AKTS

Aktis Oncology, Inc. Common stock

NASDAQ: AKTS · HEALTHCARE · BIOTECHNOLOGY

$19.73
-5.13% today

Updated 2026-06-05

Market cap
$1.12B
P/E ratio
P/S ratio
135.77x
EPS (TTM)
$-1.21
Dividend yield
52W range
$15 – $29
Volume
0.2M

Aktis Oncology, Inc. Common stock (AKTS) Insider transactions

Net insider activity
Net buying (3,295,238 shares)
Buy transactions
47
Sell transactions
53

All transactions

DateInsiderTitleTypeSharesPriceValue
2024-01-29SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy1,310,000$0.50$655000.00
2024-01-29GEISS, ARTHURDirectorBuy50,000$0.50$25000.00
2024-01-29BOLLER, KENNETHCFOBuy60,000$0.50$30000.00
2024-01-29AICHELE, DAVIDEVP of Business DevelopmentBuy80,000$0.50$40000.00
2023-12-18BOLLER, KENNETHCFOSale1,200$0.72$864.72
2023-12-18AICHELE, DAVIDEVP of Business DevelopmentSale1,500$0.72$1083.00
2023-11-21BOLLER, KENNETHCFOSale1,700$0.59$1001.30
2023-11-21AICHELE, DAVIDEVP of Business DevelopmentSale2,600$0.59$1534.78
2023-11-06RUDY, SUZANNE BDirectorBuy108,250
2023-11-06PETOCK, MICHELLEDirectorBuy185,000
2023-11-06NEAL, JERRY DDirectorBuy125,750
2023-11-06MCMAHON, JEFFREYDirectorBuy78,250
2023-11-06MCGUIRE, JAMES MICHAELDirectorBuy83,500
2023-11-06GEISS, ARTHURDirectorBuy138,333
2023-11-06DENBAARS, STEVENDirectorBuy76,500
2023-11-06DENBAARS, STEVENDirectorBuy38,250
2023-09-26SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy80,000
2023-09-13BOLLER, KENNETHCFOBuy40,000
2023-09-13AICHELE, DAVIDEVP of Business DevelopmentBuy40,000
2023-09-11BOLLER, KENNETHCFOSale3,900$1.10$4290.00
2023-09-11AICHELE, DAVIDEVP of Business DevelopmentSale5,300$1.09$5777.00
2023-08-18DENBAARS, STEVENDirectorSale7,000$1.83$12810.00
2023-03-23PETOCK, MICHELLEDirectorBuy24,151
2023-03-09MCGUIRE, JAMES MICHAELDirectorBuy2,002
2023-02-10BOLLER, KENNETHCFOSale800$4.37$3496.00
2023-01-24SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy327,273$2.75$900000.75
2023-01-24DENBAARS, STEVENDirectorBuy18,182$2.75$50000.50
2022-12-20SHEALY, JEFFREY B.Director, Chief Executive OfficerSale2,340$2.84$6645.60
2022-12-19BOLLER, KENNETHCFOSale1,200$2.92$3504.00
2022-12-19AICHELE, DAVIDEVP of Business DevelopmentSale1,480$3.14$4647.20
2022-12-06DENBAARS, STEVENDirectorSale7,000$3.57$24990.00
2022-11-28SHEALY, JEFFREY B.Director, Chief Executive OfficerSale1,950$3.54$6903.00
2022-11-23BOLLER, KENNETHCFOSale1,200$3.52$4224.00
2022-11-23AICHELE, DAVIDEVP of Business DevelopmentSale1,850$3.52$6512.00
2022-11-21SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy50,000
2022-11-21BOLLER, KENNETHCFOBuy25,000
2022-11-21AICHELE, DAVIDEVP of Business DevelopmentBuy35,000
2022-11-10RUDY, SUZANNE BDirectorBuy113,152
2022-11-10NEAL, JERRY DDirectorBuy65,722
2022-11-10MCMAHON, JEFFREYDirectorBuy84,146
2022-11-10MCGUIRE, JAMES MICHAELDirectorBuy40,766
2022-11-10GEISS, ARTHURDirectorBuy72,299
2022-11-10DENBAARS, STEVENDirectorBuy39,982
2022-09-09SHEALY, JEFFREY B.Director, Chief Executive OfficerSale3,900$4.30$16770.00
2022-09-06DENBAARS, STEVENDirectorSale7,000$3.90$27300.00
2022-08-29SHEALY, JEFFREY B.Director, Chief Executive OfficerSale3,900$4.54$17706.00
2022-08-29BOLLER, KENNETHCFOSale2,400$4.53$10872.00
2022-08-29AICHELE, DAVIDEVP of Business DevelopmentSale3,700$4.53$16761.00
2022-08-22BOLLER, KENNETHCFOSale1,500$4.62$6930.00
2022-08-22AICHELE, DAVIDEVP of Business DevelopmentSale1,480$4.62$6837.60
2022-07-18AICHELE, DAVIDEVP of Business DevelopmentSale2,313$3.68$8511.84
2022-06-20GEISS, ARTHURDirectorSale10,000
2022-06-20GEISS, ARTHURDirectorBuy10,000$1.50$15000.00
2022-06-06DENBAARS, STEVENDirectorSale7,000$4.48$31360.00
2022-04-08AICHELE, DAVIDEVP of Business DevelopmentSale5,000$5.93$29650.00
2022-02-17GEISS, ARTHURDirectorSale20,000
2022-02-17GEISS, ARTHURDirectorBuy20,000$1.50$30000.00
2022-02-14DENBAARS, STEVENDirectorSale8,013
2022-02-14DENBAARS, STEVENDirectorBuy8,013$6.24$50001.12
2022-02-10SHEALY, JEFFREY B.Director, Chief Executive OfficerSale15,000
2022-02-10SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy15,000$7.12$106800.00
2022-02-10BOLLER, KENNETHCFOBuy15,000
2022-02-10BOLLER, KENNETHCFOBuy10,000
2022-02-07MCGUIRE, JAMES MICHAELDirectorBuy17,800$5.62$100036.00
2022-01-11DENBAARS, STEVENDirectorSale7,000$5.91$41370.00
2021-12-20BOLLER, KENNETHInterim CFOSale2,100$6.69$14049.00
2021-12-20AICHELE, DAVIDEVP of Business DevelopmentSale1,480$6.64$9827.20
2021-12-17SHEALY, JEFFREY B.Director, Chief Executive OfficerSale13,928$7.01$97635.28
2021-11-23BOLLER, KENNETHInterim CFOSale900$6.97$6273.00
2021-11-23AICHELE, DAVIDEVP of Business DevelopmentSale1,850$6.77$12524.50
2021-11-09RUDY, SUZANNE BDirectorSale12,731$8.11$103248.41
2021-10-29GEISS, ARTHURDirectorSale10,000$7.47$74700.00
2021-10-28RUDY, SUZANNE BDirectorBuy22,543
2021-10-28NEAL, JERRY DDirectorBuy27,456
2021-10-28MCMAHON, JEFFREYDirectorBuy17,576
2021-10-28MCGUIRE, JAMES MICHAELDirectorBuy17,030
2021-10-28GEISS, ARTHURDirectorBuy22,652
2021-10-28DENBAARS, STEVENDirectorBuy16,703
2021-10-11DENBAARS, STEVENDirectorSale7,000$8.08$56560.00
2021-09-27AICHELE, DAVIDEVP of Business DevelopmentSale1,388$10.60$14712.80
2021-09-09SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy50,000
2021-09-09SHEALY, JEFFREY B.Director, Chief Executive OfficerBuy50,000
2021-08-30BOLLER, KENNETHInterim CFOSale900$10.00$9000.00
2021-08-30AICHELE, DAVIDEVP of Business DevelopmentSale1,850$9.04$16724.00
2021-08-27BOLLER, KENNETHInterim CFOBuy25,000
2021-08-27BOLLER, KENNETHInterim CFOBuy15,000
2021-08-27AICHELE, DAVIDEVP of Business DevelopmentBuy40,000
2021-08-27AICHELE, DAVIDEVP of Business DevelopmentBuy25,000
2021-08-23HOULDEN, ROHANChief Product OfficerSale880$8.15$7172.00
2021-08-20BOLLER, KENNETHInterim CFOSale1,200$8.24$9888.00
2021-08-20AICHELE, DAVIDEVP of Business DevelopmentSale1,480$8.23$12180.40
2021-07-19HOULDEN, ROHANChief Product OfficerSale1,375$8.96$12320.00
2021-07-16AICHELE, DAVIDEVP of Business DevelopmentSale2,313$9.37$21672.81
2021-07-12DENBAARS, STEVENDirectorSale7,000$9.93$69510.00
2021-04-12DENBAARS, STEVENDirectorSale7,000$12.00$84000.00
2021-04-08SHEALY, JEFFREY B.Director, Chief Executive OfficerSale100,000$12.03$1.20M
2021-04-07SHEALY, JEFFREY B.Director, Chief Executive OfficerSale100,000$12.51$1.25M
2021-03-22AICHELE, DAVIDEVP of Business DevelopmentSale5,000$13.72$68600.00
2021-03-17BOLLER, KENNETHInterim CFOSale1,442$13.99$20173.58
2021-03-16SHEALY, JEFFREY B.Director, Chief Executive OfficerSale100,000$13.32$1.33M

Frequently asked questions

Are AKTS insiders buying or selling?

Over the transactions on record, AKTS insiders have been net sellers, with about $4.81M in stock sold across 53 sales, against 11 open-market purchases.

Does insider selling at AKTS mean the stock will fall?

Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.

Which AKTS insiders are selling the most?

Recent selling is concentrated in a few names. SHEALY, JEFFREY B. accounts for the largest share on record, with about $3.93M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.